QuidelOrtho Corporation (NASDAQ: QDEL) is a Healthcare company (Medical - Specialties) with a market capitalization of $677M. The Maz Rating grades it against the other companies in its sector.
QuidelOrtho Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $9.87, QuidelOrtho Corporation trades at 0.3x sales and 0.4x book value, with an EV/EBITDA of 11.1. Over the last twelve months it generated about $2.6B of revenue and a net loss of $370M. It runs a gross margin of 44.2%, an operating margin of -4.7% and a net margin of -14.2%. It shows return on equity of -20.1%, return on invested capital of -2.4% and a free cash flow yield of -17.4%. On the balance sheet: a debt-to-equity ratio of 1.74 and a current ratio of 1.36. Over the past 52 weeks the share price ranged from $9.82 to $35.58, with a beta of 0.68.
QuidelOrtho Corporation does not currently pay a dividend.
15 Wall Street analyst ratings cover the stock: 6 Buy, 7 Hold and 2 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.